Your browser doesn't support javascript.
loading
A Novel Nonsense Mutation in FERMT3 Causes LAD-III in a Pakistani Family.
Shahid, Saba; Zaidi, Samreen; Ahmed, Shariq; Siddiqui, Saima; Abid, Aiysha; Malik, Shabbir; Shamsi, Tahir.
Afiliação
  • Shahid S; Department of Genomics and Clinical Genetics, National Institute of Blood Diseases and Bone Marrow Transplantation, Karachi, Pakistan.
  • Zaidi S; Department of Pediatrics, National Institute of Blood Diseases and Bone Marrow Transplantation, Karachi, Pakistan.
  • Ahmed S; Department of Genomics and Clinical Genetics, National Institute of Blood Diseases and Bone Marrow Transplantation, Karachi, Pakistan.
  • Siddiqui S; Department of Genomics and Clinical Genetics, National Institute of Blood Diseases and Bone Marrow Transplantation, Karachi, Pakistan.
  • Abid A; Center of Human Genetics and Molecular Medicine, Sindh Institute of Urology and Transplantation, Karachi, Pakistan.
  • Malik S; Department of Pediatrics, National Institute of Blood Diseases and Bone Marrow Transplantation, Karachi, Pakistan.
  • Shamsi T; Department of Clinical Hematology, National Institute of Blood Diseases and Bone Marrow Transplantation, Karachi, Pakistan.
Front Genet ; 10: 360, 2019.
Article em En | MEDLINE | ID: mdl-31068971
ABSTRACT
Leukocyte adhesion deficiency-III (LAD3) is an extremely rare primary immunodeficiency disorder, transmitted with autosomal-recessive inheritance. It is caused by genetic alteration in the FERMT3 gene, which leads to abnormal expression of kindlin-3. This cytoplasmic protein is highly expressed in leukocytes and platelets, and acts as an important regulator of integrin activation. LAD3 has features like bleeding syndrome of Glanzmann-type and leukocyte adhesion deficiency. FERMT3 mutation(s) have not been well characterized in Pakistani patients with LAD3. In this study, an infant and his family of Pakistani origin, presenting with clinical features of LAD, were investigated to determine the underlying genetic defect. Targeted next generation sequencing (TGS) and Sanger sequencing were performed to identify and confirm the causative mutations, respectively, and their segregation within the family. A novel, homozygous FERMT3 nonsense mutation (c.286C > T, p.Q96∗) was found in the proband, and its co-segregation with LAD3 phenotype within the family was consistent with an autosomal recessive inheritance. Both parents were carriers of the same mutation. This family was offered prenatal diagnosis during first trimester of the subsequent pregnancy; the fetus carried the variant. In conclusion, our study is the first report to identify the novel homozygous variant c.286C > T, p.Q96∗in the FERMT3 gene, which might be the causative mutation for LAD3 patients of Pakistani origin.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article